SYNTHESIS
Papers
1356
† Present address: Department of Chemistry, University of North
Dakota, Grand Forks, ND 58202 USA, E-mail: mlaksh-
man@mail.chem.und.nodak.edu, tel +1(701)777-2495, fax
+1(701) 777-2331.
(9) Rudolph, J.; Sennhenn, P. C.; Vlaar, C. P.; Sharpless, K. B.
Angew. Chem., Int. Ed. Engl. 1996, 35, 2810.
Li, G.; Angert, H. H.; Sharpless, K. B. Angew. Chem., Int. Ed.
Engl. 1996, 35, 2813.
‡ Present address: PE Applied Biosystems, 850 Lincoln Center
Drive, Foster City, CA 94404, USA.
§ Present address: Swiss Federal Institute for Environmental Sci-
ence and Technology (EAWAG), Department of Microbiology,
Ueberlandstrasse 133, CH-8600 Dübendorf, Switzerland, E-mail:
(10) Senanayake, C. H.; Roberts, F. E.; DiMichele, L. M.; Ryan, K.
M.; Liu, J.; Fredenburgh, L. E.; Foster, B. S.; Douglas, A. W.;
Larsen, R. D.; Verhoeven, T. R.; Reider, P. J. Tetrahedron Lett.
1995, 36, 3993.
(11) Senanayake, C. H.; DiMichele, L. M.; Liu, J.; Fredenburgh, L.
E.; Ryan, K. M.; Roberts, F. E.; Larsen, R. D.; Verhoeven, T.
R.; Reider, P. J. Tetrahedron Lett. 1995, 36, 7615.
(12) For an excellent review see: Hudlicky, T.; Entwistle, D. A.; Pit-
zer, K. K.; Thorpe, A. J. Chem. Rev. 1996, 96, 1195.
(13) Lakshman, M. K.; Zajc, B. Tetrahedron Lett. 1996, 37, 2529.
(14) Boyd, D. R.; Sharma, N. D.; Bowers, N. I.; Goodrich, P. A.;
Groocock, M. R.; Blacker, A. J.; Clarke, D. A.; Howard, T.;
Dalton, H. Tetrahedron: Asymmetry 1996, 7, 1559.
(15) Resnick, S. M.; Torok, D. S.; Gibson, D. T. J. Org. Chem. 1995,
60, 3546.
(1) Roxburgh, C. J. Synthesis 1996, 307.
(2) A class of HIV type 1 protease inhibitors, L-735,524, L-
704,486, L-685,434, L-689,502, utilizes the (1S,2R)-1-amino-
2-hydroxyindane core: Vacca, J. P.; Dorsey, B. D.; Schleif, W.
A.; Levin, R. B.; McDaniel, S. L.; Darke, P. L.; Zugay, J.; Quin-
tero, J. C.; Blahy, O. M.; Roth, E.; Sardana, V. V.; Schlabach,
A. J.; Graham, P. I.; Condra, J. H.; Gotlib, L.; Holloway, M. K.;
Lin, J.; Chen, I.-W.; Vastag, K.; Ostovic, D.; Anderson, P. S.;
Emini, E. A.; Huff, J. R. Proc. Natl. Acad. Sci. 1994, 91, 4096.
(3) Radesca, L.; Bowen, W. D.; Di Paolo, L.; de Costa, B. R.
J. Med. Chem. 1991, 34, 3058.
(16) Resnick, S. M.; Gibson, D. T. Appl. Environ. Microbiol. 1996,
62, 1364.
(17) Induced cells of strain PpF39/D (300 mL) incubated for 24 h
with 300 mg 2-indanol yielded 217 mg of crude products. Radi-
al dispersion chromatography was used to isolate (–)-(1S,2R)-
1,2-dihydroxyindane [(–)-1, 92% ee, 110 mg, >85% relative
product yield], trans-1,2-dihydroxyindane (13 mg), and 2-hy-
droxyindan-1-one (<2 mg). The enantiomeric purity of (–)-1
was determined by chiral stationary phase HPLC.
(18) Ghosh, A. K.; Kincaid, J. F.; Haske, M. G. Synthesis 1997, 541.
(19) Igarashi, Y.; Otsutomo, S.; Harada, M.; Nakano, S.; Watanabe,
S. Synthesis 1997, 549.
Rajagopalan, P.; Scribner, R. M.; Pennev, P.; Schmidt, W. K.;
Tam, S. W.; Steinfels, G. F.; Cook, L. Bioorg. Med. Chem. Lett.
1992, 2, 715.
Rajagopalan, P.; Scribner, R. M.; Pennev, P.; Mattei, P. L.; Ke-
zar, H. S.; Cheng, C. Y.; Cheeseman, R. S.; Ganti, V. R.; John-
son, A. L.; Wuonola, M. A.; Schmidt, W. K.; Tam, S. W.;
Steinfels, G. F.; Cook, L. Bioorg. Med. Chem. Lett. 1992, 2,
721.
(4) For some examples on the synthesis of the taxol C-13 side-chain
see: Hönig, H.; Seufer-Wasserthal, P.; Weber, H. Tetrahedron
1990, 46, 3841.
(20) Lakshman, M.; Nadkarni, D. V.; Lehr, R. E. J. Org. Chem.
1990, 55, 4892.
(21) Resnick, S. M.; Lee, K.; Gibson, D. T. J. Indust. Microbiol.
1996, 17, 438.
(22) Burgess, K.; Porte, A. M. Angew. Chem., Int. Ed. Engl. 1994,
33, 1182.
(23) Gibson, D. T.; Zylstra, G. J.; Chauhan, S. In Pseudomonas: Bio-
transformations, Pathogenesis, and Evolving Biotechnology;
Silver, S.; Chakrabarty, A. M.; Iglewski, B.; Kaplan, S., Eds.;
American Society for Microbiology: Washington, D.C., 1990;
pp 121.
Denis, J.-N.; Correa, A.; Greene, A. E. J. Org. Chem. 1991, 56,
6939.
Georg, G. I.; Mashava, P. M.; Akgün, E.; Milstead, M. W.
Tetrahedron Lett. 1991, 32, 3151.
Holton, R. A.; Liu, J. H. Bioorg. Med. Chem. Lett. 1993, 3,
2475.
Wang, Z.-M.; Kolb, H. C.; Sharpless, K. B. J. Org. Chem. 1994,
59, 5104.
(5) Ager, D. J.; Prakash, I.; Schaad, D. R. Chem. Rev. 1996, 96,
835.
(6) Ghosh, A. K.; Chen, Y. Tetrahedron Lett. 1995, 36, 6811.
Ghosh, A. K.; Mathivanan, P.; Cappiello, J. Tetrahedron Lett.
1996, 37, 3815.
(24) Boyd, D. R.; Sharma, N. D.; Dalton, H. In Organic Reactivity:
Physical and Biological Aspects; Golding, B. T.; Griffin, R. J.;
Maskill, H., Eds.; The Royal Society of Chemistry: Cambridge,
UK, 1995; pp 130.
(25) Gibson, D. T.; Resnick, S. M.; Lee, K.; Brand, J. M.; Torok, D.
S.; Wackett, L. P.; Schocken, M. J.; Haigler, B. E. J. Bacteriol.
1995, 177, 2615.
(26) Imuta, M.; Ziffer, H. J. Org. Chem. 1978, 43, 4540.
(27) Jerina, D. M.; Daly, J. W.; Jeffrey, A. M.; Gibson, D. T. Arch.
Biochem. Biophys. 1971, 142, 394.
(28) Jerina, D. M.; Selander, H.; Yagi, H.; Wells, M. C.; Darvey, J.
F.; Mahadevan, V.; Gibson, D. T. J. Am. Chem. Soc. 1976, 98,
5988.
Ghosh, A. K.; Onishi, M. J. Am. Chem. Soc. 1996, 118, 2527.
Davies, I. W.; Gerena, L.; Lu, N.; Larsen, R. D.; Reider, P. J.
J. Org. Chem. 1996, 61, 9629.
Hett, R.; Fang, Q. K.; Gao, Y.; Hong, Y.; Butler, H. T.; Nie, X.;
Wald, S. A. Tetrahedron Lett. 1997, 38, 1125.
Sibi, M. P.; Ji, J. J. Org. Chem. 1997, 62, 3800.
Palmer, M.; Walsgrove, T.; Wills, M. J. Org. Chem. 1997, 62,
5226.
(7) Bellucci, C. M.; Bergamini, A.; Cozzi, P. G.; Papa, A.; Taglia-
vini, E.; Umani-Ronchi, A. Tetrahedron: Asymmetry 1997, 8,
895.
(8) Sharpless, K. B.; Chong, A. O.; Oshima, K. J. Org. Chem. 1976,
41, 177.
(29) Since submission of this manuscript other authors have reported
difficulties in derivatizing propranolol, a β-amino alcohol, with
phenylboronic acid: Hori, M.; Janda, K. D. J. Org. Chem. 1998,
63, 889.
Herranz, E.; Sharpless, K. B. J. Org. Chem. 1978, 43, 2544.